For years, the IPBS took part in various European schemes, recruited MSCA or MSCA/Respire Foundation postdoctoral fellows and trained ERASMUS graduated/post-graduate students. Notably, IPBS has been part of the TBVAC Consortium coordinated by the Tuberculosis Vaccine Initiative which is awarded European fundings since 2000. More recently, IPBS participation in European consortium as well as the number of individual research grants funded by Horizon 2020 and Horizon Europe frameworks significantly increased.
There are currently 9 running European project at IPBS:
1 ERC Starting Grant: INFLAME project led by Etienne Meunier aims to go beyond the canonical roles of inflammasomes in the defense against infections, by investigating the not yet discovered immune functions of novel inflammasome-derived components.
1 MSCA Postdoctoral Fellowship:MTB-DETOX project led by Pierre Dupuy, in Neyrolles Group aims to study the molecular mechanisms of resistance to metal stress in Mycobacterium tuberculosis.
1 collaborative Research and Innovation Action funded under Horizon 2020 framework in the area of “prevention, treatment and cure of infectious diseases”: SMA-TB project is aimed to elaborate host-directed therapies against tuberculosis; it involves the team headed by Jérôme Nigou.
2 MSCA Doctoral Networks: PROTrEIN project aims to study the contribution of artificial intelligence to proteomics data analysis; two PhD students have been recruited to work on this project in the proteomic group led by Odile Schiltz [https://www.ipbs.fr/protrein-new-european-network-study-contribution-artificial-intelligence-proteomics-data-analysis]. PROSTAMET project aims to decipher the Metabolic symbiosis between bone-marrow adipocytes and prostate cancer cells and its role in bone metastasis progression. One PhD students will be recruited in 2023 to work on this project in the group led by Catherine Muller.
2 collaborative Research and Innovation Action funded under Horizon Europe framework in the field of Environment and Health, under the heading “Living and working in a health-promoting environment”: ETAIN and GOLIATH projects, which aim to evaluate the impact of exposure to radiofrequency electromagnetic fields (RF-EMF) on human, ecosystem and global health, in order to inform current policy and regulatory frameworks, involve the team headed by Marie-Pierre Rols.
2 collaborative Research and Innovation Action funded under Horizon Europe program (Pillar 2 – Health Cluster) in the field of “Tackling diseases and reducing disease burden” TBVAC-HORIZON and ITHEMYC projects aim to reduce the burden of tuberculosis by developing new prevention and treatment strategies. They involve scientists from the 4 groups headed by Olivier Neyrolles, Etienne Meunier, Jérôme Nigou and Jean-Philippe Girard.
Many intra-European bilateral actions with Poland, Portugal, Spain, the UK, etc. and 2 PI-to-PI International Emerging Actions with the Netherlands and Germany have already borne fruit. A long-term collaboration initiated with the University of Ljubljana and involving the Institute of Oncology of Ljubljana and the University of Primorska (Slovenia) in a European Associated Laboratory in the field of Pulse Electric Fields Applications in Biology and Medecine has been particularly remarkable.
Some IPBS teams are also members of European programs of cross-border cooperation, through the interregional POCTEFA.